UPDATE : Thursday, August 13, 2020
상단여백
Covid-19 makes Vivozon halt P3 trial of nonnarcotic analgesics in US
said that it has halted its phase 3b clinical trials for using opiranserin,...
by Lee Han-soo  |  2020-08-13 17:27
라인
Takeda expects more effective IBD treatment with Kynteles' expanded reimbursement
Takeda Korea is strengthening its position in the domestic inflammatory bow...
by Lee Han-soo  |  2020-08-12 17:45
라인
Roche’s Tecentriq-Avastin combo wins nod to treat hepatocellular carcinoma
Roche has become the first company in Korea to win the regulator’s nod to u...
by Lee Han-soo  |  2020-08-12 14:35
라인
Daewoong to conduct P1 trial of Covid-19 treatment in India
Daewoong Pharmaceutical said that the Indian health regulators have approve...
by Lee Han-soo  |  2020-08-11 17:48
라인
Curocell draws $37-million investment, steps up trials of CAR-T therapy
Curocell, Korea’s first developer of chimeric antigen receptor T (CAR-T) ce...
by Park Gi-taek  |  2020-08-10 17:28
라인
Rheumatoid arthritis drug Rinvoq gets insurance benefit
AbbVie Korea’s rheumatoid arthritis treatment Rinvoq SR Tab. 15mg (ingredie...
by Kim Eun-young  |  2020-08-07 14:34
라인
Regulator OKs Pfizer's BRCA mutation breast cancer treatment
Pfizer Korea said that the Ministry of Food and Drug Safety has approved Ta...
by Lee Han-soo  |  2020-08-05 16:02
라인
Hanmi, MSD sign licensing agreement for hepatitis treatment
Hanmi Pharmaceutical said it has entered into an exclusive licensing agreem...
by Shim Hyun-tai  |  2020-08-05 15:24
라인
Korean biopharmaceutical market expands on biosimilar export growth
The domestic biopharmaceutical market grew last year, mainly boosted by exp...
by Kim Chan-hyuk  |  2020-08-04 15:46
라인
Medpacto to unveil trial results at European conference
Medpacto, a biomarker-based new drug developer, said it would present the p...
by Lee Han-soo  |  2020-08-04 14:44
라인
Drugmakers tap home fitness market amid Covid-19
Pharmaceutical companies are eyeing on consumers exercising at home amid Co...
by Kim Chan-hyuk  |  2020-08-04 11:22
라인
Medpacto to develop test kit for metastatic breast cancer
MedPacto, a biomarker-based cancer drug developer, and medical equipment ma...
by Shim Hyun-tai  |  2020-08-03 17:51
라인
AbbVie’s hepatitis C drug Maviret gets expanded regulatory nod
AbbVie received the local regulatory approval on July 31 to shorten the tre...
by Shim Hyun-tai  |  2020-08-03 17:51
라인
Boryung’s SCLC treatment wins orphan drug status
Boryung Pharmaceutical said that the Ministry of Food and Drug Safety has g...
by Lee Han-soo  |  2020-08-03 16:48
라인
Daewoong's Q2 earnings plummet amid legal battle with Medytox
Daewoong Pharmaceutical suffered a nosediving operating margin in the secon...
by Lee Han-soo  |  2020-07-31 16:58
라인
"Multinational pharma use illegal kickbacks to benefit executives, headquarters"
A labor leader has accused some multinational pharmaceutical firms’ executi...
by Kim Yun-mi, Lee Han-soo  |  2020-07-31 13:54
라인
‘Nabota alleviates sleep bruxism’
Daewoong Pharmaceutical said that it has confirmed that Nabota, its botulin...
by Lee Han-soo  |  2020-07-30 17:23
라인
Hugel to export HA filler to Indonesia
Hugel said that it has received sales approval for Chaeum Style, a hyaluron...
by Lee Han-soo  |  2020-07-29 17:23
라인
GC applies for P2 trials of plasma therapy for Covid-19
GC said that it has applied for an investigational new drug (IND) applicati...
by Lee Han-soo  |  2020-07-29 14:45
라인
GC Labcell turns profitable in Q2
GC Labcell said that it recorded sales of 20 billion won ($16.7 million) in...
by Lee Han-soo  |  2020-07-28 14:11
여백
여백
여백
Back to Top